Philips and Volcano’s vision for the future

It has been a little over 90 days since Philips acquired Volcano. In a move to further their healthtech strategy, in particular their image-guided therapy business, Philips decided to team up with Volcano, a global leader in intravascular imaging for coronary and peripheral applications, and physiology.

“The completion of the Volcano acquisition is an important milestone in our strategy to become the leading systems integrator in the fast growing image-guided minimally invasive surgery market and accelerate our growth in that market,” said Frans van Houten, Chief Executive Officer of Royal Philips.

“The combination of Volcano’s broad portfolio of imaging and measurement catheters and Philips’ leading interventional imaging solutions allow us to provide our customers with an integrated solution to improve procedural outcomes at a decisive stage in the health continuum. ”

Image guided therapy provides major benefits for patients and healthcare systems such as reduced patient risk, higher patient throughput and lower cost.

As part of the new-found shared vision, Philips are working towards providing customers with integrated solutions to maximize efficiency in the catheter laboratory by simplifying usage and innovating interventional procedures.

Bert van Meurs, General Manager Image Guided Therapy at Philips said: “Our customers are asking us to provide more integrated solutions in order to avoid clutter in the lab, simplify usage and innovate interventional procedures, so they can treat patients more effectively and efficiently. By integrating Volcano into our Image Guided Therapy business we are adding smart catheter-based imaging and measurement devices to our strong product portfolio, to offer one of the broadest ranges of interventional solutions in the industry.”

“In addition to a complimentary solutions offering, Volcano gives us unique clinical development capabilities. Together, we will now be able to unlock new clinical solutions in applications like structural heart disease, which could not have been developed by our two companies independently,” said van Meurs.

To support the minimally invasive image guided procedures the partnership will focus on bringing to healthcare systems: 

  • Integrated solutions: From the two leading players in live image guidance with interventional X-ray systems, navigation tools and services, ultrasound, IVUS, iFR, FFR, Financing, Consultancy and Managed equipment servicing  and healthcare IT.
  • Insight & Expertise: 1,600 scientists & engineers, 8,000 patients enrolling in 10+ trials globally, $200M annual R&D reinvestment, 80,000 patents.
  • People & partnerships: Together Philips and Volcano can offer broader continued support with 300 in-lab clinical support staff, 7,000 field service engineers 1,000 physicians and staff educated peer-to-peer annually, Global network of training centers.

“The integrated tailored cath and angio lab offering will support physicians to ensure the right diagnosis and decide, guide and confirm the optimal treatment path to enable better patient outcomes and more cost effective care,” said van Meurs.

For more information please visit: